European Private Capital Transactions

With market-leading European private capital and strategic M&A capabilities and more than 175 private equity transactional lawyers worldwide, Ropes & Gray is the ideal partner for organizations looking to raise, deploy and return equity and debt capital across continental Europe and beyond.

Overview

Ropes & Gray has a longstanding reputation as one of the world’s leading law firms for private capital clients, with a specific focus on the private equity and asset management industries and strong vertical capabilities in life sciences, healthcare technology and infrastructure. The launch of our Paris office with three of the market’s top practitioners significantly enhances our European private capital and strategic M&A expertise and demonstrates our commitment to being the firm of choice for any European private capital need.

A Single, Integrated European Hub

Our London, Paris and Dublin offices operate as a single European hub offering a powerful combination of local market savvy and the unmatched resources of Ropes & Gray’s global network. Wherever they do business in Europe or around the world, clients can trust our European private equity team—working closely with colleagues worldwide—to make the right deals on the right terms, thoughtfully assess risk and make appropriate tradeoffs, and respond quickly to business demands.

We have enjoyed exponential growth during our 15 years in Europe because of our “client-first” commitment and our private equity and asset management focus. Clients such as European and US private equity firms, sovereign wealth and pension funds, asset managers, listed companies and large industrial groups turn to us to guide them on any private capital-related matter. Our experience spans a wide range of sectors, including aerospace and defense, automotive, healthcare, life sciences, technology, renewables, industrials, business services, consumer and retail.

Our European private equity team advises on:

  • Public and private mergers and acquisitions
  • Domestic and cross-border transactions
  • IPOs and take-private transactions
  • Corporate reorganizations
  • Sophisticated financings, including US/UK high yield and more innovative ACF solutions
  • All investment structures and strategies—including direct investments, co-investments and secondaries
  • Securities law
  • Acquisition finance—including leveraged buyouts, public-to-private transactions and private investments in public equity
  • Private debt
  • Real estate finance
  • Debt restructuring

Experience & Awards

Recent highlights include representing/advising:

  • Baring Private Equity Asia, now EQT Asia on its acquisition of Lumenis.
  • Avista Healthcare Partners on its acquisition of Vision Healthcare NV alongside VHC Investco. 
  • Arsenal Capital Partners on the acquisition by its portfolio company Value Demonstration Holdings LLC of Cello Health.
  • Partners Group on its investment in Rovensa.
  • GHO Capital on its acquisition of Envision Pharma.
  • Intermediate Capital Group on its acquisition of a minority stake in Workhuman.

Representative clients in Europe include:

  • 3i Group
  • Bain Capital
  • Baring Private Equity Asia, now EQT Asia 
  • Blackstone
  • Charlesbank
  • ICG
  • Nordic Capital
  • Partners Group
  • TPG

Our London team has been recognized for its work by numerous leading sources, including:

  • The Legal 500 UK 2016-2017 – Ranked in the U.K. as a leading “Private Equity: Transactions – Large Cap Deal Capability” practice, with two attorneys ranked as leaders.
  • IFLR – Ranked in the U.K. for “Private Equity Transactions.”
  • Chambers UK 2017 – Ranked in the U.K. as a leading “Private Equity: Buyouts: High-End Capability” practice, with three attorneys ranked as leaders.
"Thanks to a lean and dynamic team, they provided robust and skilled support while managing costs to expectations."
Chambers UK 2017, Private Equity: Buyouts: High-End Capability